Inari Medical Inc logo

NARI

Inari Medical Inc

$76.29

Earnings Summary

Revenue
$92.74Mn
Net Profits
$-10.19Mn
Net Profit Margins
-10.98%

Highlights

Revenue:

Inari Medical Inc’s revenue jumped 46.16% since last year same period to $92.74Mn in the Q2 2022. On a quarterly growth basis, Inari Medical Inc has generated 6.91% jump in its revenue since last 3-months.

Net Profits:

Inari Medical Inc’s net profit fell -350.42% since last year same period to $-10.19Mn in the Q2 2022. On a quarterly growth basis, Inari Medical Inc has generated -225.57% fall in its net profits since last 3-months.

Net Profit Margins:

Inari Medical Inc’s net profit margin fell -271.33% since last year same period to -10.98% in the Q2 2022. On a quarterly growth basis, Inari Medical Inc has generated -204.53% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Inari Medical Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.23
EPS Estimate Current Year
-0.23

Highlights

EPS Estimate Current Quarter:

Inari Medical Inc’s earning per share (EPS) estimates for the current quarter stand at -0.23 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Inari Medical Inc’s earning per share (EPS) estimates for the current year stand at -0.23.

Key Ratios

Key ratios of the Inari Medical Inc post its Q2 2022 earnings

Earning Per Share (EPS)
-0.19
Return on Assets (ROA)
-0.01
Return on Equity (ROE)
-0.05
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Inari Medical Inc’s earning per share (EPS) fell -371.43% since last year same period to -0.19 in the Q2 2022. This indicates that the Inari Medical Inc has generated -371.43% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Inari Medical Inc’s return on assets (ROA) stands at -0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Inari Medical Inc’s return on equity (ROE) stands at -0.05.

Dividend Per Share (DPS):

Inari Medical Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-03
-0.23
-0.19
17.39%
2022-05-04
-0.09
-0.06
33.33%

Company Information

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.

Organisation
Inari Medical Inc
Employees
456
Industry
Health Technology